跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
大數據科技及管理研究所
臺北醫學大學
管理學院
電話
+886-2-6638-2736#1105
電子郵件
[email protected]
網站
http://bigdata2.tmu.edu.tw/index.php
郵寄地址
在地圖上顯示
概覽
指紋
網路
專家檔案
(8)
專案
(76)
研究成果
(507)
資料集
(16)
指紋
查看啟用 大數據科技及管理研究所 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Cohort Analysis
71%
Hazard Ratio
56%
Malignant Neoplasm
44%
Disease
41%
COVID-19
39%
Randomized Controlled Trial
35%
Meta-Analysis
33%
Systematic Review
32%
Influenza Vaccination
32%
Chronic Kidney Disease
30%
Lung Cancer
28%
Breast Cancer
27%
Odds Ratio
23%
Cancer Risk
21%
Health Care
21%
Apoplexy
20%
Chronic Obstructive Pulmonary Disease
19%
Emergency Department
18%
Electronic Patient Record
17%
Drug Therapy
17%
Electronic Health Record
16%
Injury
15%
Maturity Onset Diabetes of the Young
15%
Case-Control Study
15%
Computer Assisted Tomography
14%
Drug-Eluting Stent
14%
Network Meta-Analysis
14%
Proton-Pump Inhibitor
14%
4 Iodo 2,5 Dimethoxyamphetamine
14%
Proportional Hazards Model
13%
Cancer Therapy
13%
Outpatient
13%
Infection
12%
Autoimmune Disease
12%
Rheumatoid Arthritis
12%
Patient with Type 2 Diabetes
12%
Diabetes
11%
Middle Age
11%
Retrospective Cohort Study
10%
Surgical Technique
10%
Clinician
10%
Diabetes Mellitus
10%
Autoimmune Rheumatic Disease
10%
Parkinson's Disease
10%
Hepatocellular Carcinoma
10%
Prostate Cancer
10%
Typical Antipsychotic
10%
Pediatrics
10%
Non Small Cell Lung Cancer
10%
Thermal Burn
10%
Physician
10%
Blood Pressure
10%
Radiation Therapy
10%
Retrospective Study
10%
Adverse Event
10%
Logistic Regression Analysis
9%
Patient Care
9%
Metabolic Syndrome
9%
Prevalence
9%
Cancer Registry
9%
Sjoegren Syndrome
9%
Diagnosis
9%
Clinical Research
8%
Systemic Lupus Erythematosus
8%
Cancer Diagnosis
8%
Anemia
8%
Population Research
8%
Cross Sectional Study
8%
Eye Disease
7%
Metastatic Carcinoma
7%
Symptomatic Treatment
7%
Preventive Medicine
7%
Symptom
7%
Thyroid Disease
7%
Neonate
7%
Atrial Fibrillation
7%
New-Onset Atrial Fibrillation
7%
Computerized Physician Order Entry
7%
Thyroid Cancer
7%
Brain Ischemia
7%
Myocardial Infarction
7%
Gout
7%
Pulse Wave Velocity
7%
Dry Eye
7%
End Stage Liver Disease
7%
Head and Neck Squamous Cell Carcinoma
7%
Heart Failure
7%
Mammography
7%
Necrotizing Enterocolitis
7%
Obstructive Sleep Apnea
7%
Lung Cancer Survival
7%
Radiation Exposure
7%
Cancer Mortality
7%
Traditional Chinese Medicine
7%
Ischemic Heart Disease
7%
Awareness
6%
Cooperation
6%
Medical Care
6%
Medical Informatics
6%
Quality of Life
6%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Disease
81%
Malignant Neoplasm
80%
Vaccination Policy
35%
Comorbidity
30%
Breast Cancer
29%
Lung Cancer
25%
Chronic Kidney Failure
25%
Randomized Controlled Trial
23%
Prostate Cancer
21%
Non Insulin Dependent Diabetes Mellitus
20%
Acetylsalicylic Acid
19%
Case-Control Study
19%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
18%
All Cause Mortality
18%
Cardiovascular Disease
17%
Brain Ischemia
17%
Prevalence
16%
Observational Study
16%
Coronavirinae
16%
Chronic Obstructive Lung Disease
16%
Acute Heart Infarction
15%
Statin (Protein)
15%
Proton Pump Inhibitor
14%
Liver Cell Carcinoma
14%
Autoimmune Disease
13%
Heart Failure
13%
Non Small Cell Lung Cancer
13%
Metformin
13%
Bisphosphonic Acid Derivative
12%
Clinical Research
11%
Adverse Event
11%
Atrial Fibrillation
11%
Cancer Registry
11%
Chemotherapy
11%
Sjoegren Syndrome
11%
Dry Eye
10%
Typical Antipsychotic
10%
Syndrome
10%
Retrospective Study
10%
Sleep Disordered Breathing
10%
Gout
10%
Eye Disease
10%
Traditional Chinese Medicine
10%
HIV
10%
Angiotensin
10%
Rheumatoid Arthritis
10%
Systemic Lupus Erythematosus
10%
Infection
9%
Androgen
9%
Ischemic Heart Disease
9%
Hepatitis C
9%
Heart Infarction
8%
Tree
8%
Cardiovascular Risk
8%
Influenza Vaccine
8%
Angiotensin Receptor Antagonist
8%
New-Onset Atrial Fibrillation
8%
Epidermal Growth Factor Receptor
8%
Intubation
8%
Autoantibodies
8%
Diabetes Mellitus
8%
Antidiabetic Agent
7%
Injury
7%
Thyroid Disease
7%
Survival Rate
7%
Mortality Rate
7%
Antiplatelet
7%
Drug Development
7%
Clopidogrel
7%
Pancreas Cancer
7%
Combination Therapy
7%
Immunoglobulin M
7%
Neoplasm
7%
Brain Hemorrhage
7%
Cancer Survival
7%
4 Hydroxynonenal
7%
Rheumatic Disease
7%
End Stage Liver Disease
7%
Benzodiazepine
7%
Metabolic Syndrome X
7%
Immune Checkpoint Inhibitor
7%
Agar
7%
Microparticle
7%
Pulmonary Drug Delivery
7%
Interferon
7%
Parkinson's Disease
7%
Sepsis
7%
Mannitol
7%
Head and Neck Squamous Cell Carcinoma
7%
Protein Tyrosine Kinase Inhibitor
7%
End Stage Renal Disease
7%
Gonadorelin Antagonist
7%
QT Prolongation
7%
Dipeptidyl Carboxypeptidase Inhibitor
6%
Isoniazid
6%
Non ST Segment Elevation Myocardial Infarction
6%
Drug Interaction
6%
Overall Survival
6%
Therapeutic Effect
6%
Nursing and Health Professions
Disease
29%
Cohort Analysis
27%
Confidence Interval
25%
Emergency Ward
22%
Meta Analysis
21%
Breast Cancer
21%
Symptom
17%
Medical Record
15%
Health Care Personnel
14%
Malignant Neoplasm
14%
Electronic Health Record
14%
Systematic Review
14%
Drug Therapy
14%
Chronic Kidney Failure
14%
Hospital
13%
Psychometry
13%
National Health Insurance
13%
Outpatient
13%
Electronic Medical Record
12%
Health Service
12%
Ward
11%
Odds Ratio
11%
Receiver Operating Characteristic
11%
Hazard Ratio
11%
Health Care Cost
11%
Cancer Therapy
11%
Intensive Care Unit
10%
Human Immunodeficiency Virus
10%
4 Iodo 2,5 Dimethoxyamphetamine
10%
Typical Antipsychotic
10%
Nursing Process
10%
Diabetes Mellitus
10%
Pilot Study
10%
Obstructive Lung Disease
10%
Patient Care
9%
Area under the Curve
9%
Adverse Event
9%
Patient with Type 2 Diabetes
8%
Non Insulin Dependent Diabetes Mellitus
8%
Thermal Burn
8%
Artificial Intelligence
8%
Hospital Accreditation
8%
Eye Disease
7%
Teleconsultation
7%
Medline
7%
Health Literacy
7%
Content Validity
7%
Logistic Regression Analysis
7%
Palliative Therapy
7%
Quality of Life
7%
Public Health Informatics
7%
Influenza Vaccination
7%
Dry Eye
7%
Brain Cancer
7%
Antiretroviral Therapy
7%
Drug Eluting Stent
7%
Heart Rate Variability
7%
Nursing Staff
7%
Pressure Injury
7%
Acute Heart Infarction
7%
Accreditation
6%
Nursing Diagnosis
6%
Physician
6%
Healthcare System
6%
Prevalence
6%
Health Care Management
5%
Mass-Casualty Incident
5%
Decision Support System
5%
Medication Compliance
5%
Clinician
5%
Statin (Protein)
5%
Clinical Practice
5%
Diagnosis
5%
All Cause Mortality
5%
Infection
5%
Brain Ischemia
5%
Vaccination Policy
5%
Likert Scale
5%
Clinical Pathway
5%
Cross-Sectional Study
5%
Public Hospital
5%